The UK's National Institute for Health & Care Excellence OK's pSivida's Iluvien drug/device combo for cataract surgery patients with chronic diabetic macular edema.
pSivida (NSDQ:PSDV) said the UK's National Institute for Health & Care Excellence approved its Iluvien drug/device combination.
The approval is for cataract surgery patients who don't respond to standard treatment for diabetic macular edema, according to a press release.
Becton, Dickinson & Co. says Brazil's Secretariat of Foreign Trade is probing whether it dumped vacuum tubes onto the Brazilian market for less than their price in the U.S.
Becton Dickinson & Co. (NYSE:BDX) said a Brazilian agency today began an anti-dumping probe that's looking into sales in Brazil of its vacuum tubes used to collect blood.
Medtronic says a German court lifted the ban on sales there of its CoreValve replacement heart valve, meaning it can resume sales of the transcatheter aortic valve implant as soon as it posts a roughly $6.7 million bond.
Medtronic says a preliminary review of an Edwards Lifesciences patent for the Sapien heart valve by the European Patent Office went its way.
Baxter International warns patients on a potential software issue with its HomeChoice automated dialysis device.
Baxter (NYSE:BAX) warned patients with ascites of a potential software problem with its HomeChoice peritoneal dialysis machine that could cause low blood pressure and "hemodynamic compromise," according to a field alert.
Boston Scientific won approval from the Chinese Food and Drug Administration for its Alair bronchial thermoplasty system for treating severe asthma.
Boston Scientific (NYSE:BSX) said the Chinese FDA approved its Alair bronchial thermoplasty system for treating patients with persistent asthma.
Stereotaxis announced its Niobe system was awarded reimbursement classification in Japan, alongside releasing its preliminary 3rd quarter earnings.
Stereotaxis won Japan's highest reimbursement classification for its Niobe magnetic navigation system.
The Niobe system is now classified as a C2 medical device by Japan's Ministry of Health, Labor & Welfare, according to a press release.